Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
AUTOR(ES)
Askgaard, D S
RESUMO
A 35 year old black Somalian woman with miliary tuberculosis developed hepatotoxicity after a few days of treatment with isoniazid, rifampicin, pyrazinamide, and ethambutol. After withdrawal of all drugs the liver profile returned to normal and remained so after challenge with isoniazid. Hepatotoxicity recurred when rifampicin was added, but it was well tolerated when reintroduced without isoniazid.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=473930Documentos Relacionados
- Tuberculous pleural effusion: experience with six months of treatment with isoniazid and rifampicin.
- Treatment of lymphogranuloma venereum with rifampicin.
- Treatment of lymphogranuloma venereum with rifampicin.
- Treatment of early rheumatoid arthritis with rifampicin.
- Toxicity of isoniazid and rifampicin combination.
